The 2009 Import and Export Market for Medicaments Containing Antibiotics or Their Derivatives in Oceana

Icon Group International, Inc.
May 16, 2009
27 Pages - SKU: ICN2315294
Attention: There is an updated edition available for this report.
The US Market for Rx to OTC Switches, 7th Edition
2/2/2015 | published by: Kalorama Information
The US Market for Rx to OTC Switches Over the past 38 years the U.S. Rx-to-OTC market has grown into a $7.8 billion market. This has mainly been due to factors such as patent  |  read more...
USD 3,995
Bladder Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015
2/6/2015 | published by: DelveInsight
Bladder Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 DelveInsight’s, “Bladder Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across  |  read more...
USD 2,000
Bone Metastasis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015
2/6/2015 | published by: DelveInsight
Bone Metastasis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 DelveInsight’s, “Bone Metastasis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across  |  read more...
USD 2,000
Peritoneal Tumor-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015
2/6/2015 | published by: DelveInsight
Peritoneal Tumor-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 DelveInsight’s, “Peritoneal Tumor-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across  |  read more...
USD 2,000
Bone Sarcoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015
2/6/2015 | published by: DelveInsight
Bone Sarcoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 DelveInsight’s, “Bone Sarcoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across  |  read more...
USD 2,000
Brain Hemorrhage-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015
2/6/2015 | published by: DelveInsight
Brain Hemorrhage-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 DelveInsight’s, “Brain Hemorrhage-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across  |  read more...
USD 2,000
Brain Tumor-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015
2/6/2015 | published by: DelveInsight
Brain Tumor-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 DelveInsight’s, “Brain Tumor-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across  |  read more...
USD 2,000
Bronchiectasis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015
2/6/2015 | published by: DelveInsight
Bronchiectasis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 DelveInsight’s, “Bronchiectasis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Bronchiectasis.  |  read more...
USD 2,000
Brucellosis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015
2/6/2015 | published by: DelveInsight
Brucellosis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 DelveInsight’s, “Brucellosis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Brucellosis.  |  read more...
USD 2,000
Cachexia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015
2/6/2015 | published by: DelveInsight
Cachexia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 DelveInsight’s, “Cachexia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Cachexia.  |  read more...
USD 2,000
 

SELECT A LICENSE

    Online Download  USD 325  
    Global Site License  USD 650  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!